Compounds > 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline
Page last updated: 2024-09-03

1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline and Parkinsonian Disorders

1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Biasi, P; Kochen, W; Kohlmüller, D; Ramsay, R1

Other Studies

1 other study(ies) available for 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline and Parkinsonian Disorders

ArticleYear
The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease.
    Advances in experimental medicine and biology, 2003, Volume: 527

    Topics: Aged; Animals; Behavior, Animal; Carbolines; Cells, Cultured; Dopamine; Humans; Male; Mitochondria; Neuroglia; Neurons; Neurotoxins; Parkinson Disease; Parkinsonian Disorders; Rats; Serotonin; Trichloroethylene

2003